Court Opinion

ID: 813271
Source: CourtListenerOpinion
Date Created: 2012-12-07 21:03:49+00
Date Added: 2024-06-11T12:31:19.461714
License: Public Domain

Case: 13-1089    Document: 9      Page: 1   Filed: 12/07/2012

          NOTE: This order is nonprecedential.

   United States Court of Appeals
       for the Federal Circuit
                __________________________

    TAKEDA PHARMACEUTICALS COMPANY
 LIMITED, TAKEDA PHARMACEUTICALS NORTH
  AMERICA, INC., TAKEDA PHARMACEUTICALS,
  LLC, TAKEDA PHARMACEUTICALS AMERICA,
          INC., AND ETHYPHARM, S.A.,
                Plaintiffs-Appellees,
                            v.
    ZYDUS PHARMACEUTICALS USA, INC. AND
       CADILA HEALTHCARE, LIMITED,
             Defendants-Appellants.
                __________________________

                        2013-1089
                __________________________

    Appeal from the United States District Court for the
District of New Jersey in case no. 10-CV-1723, Judge Joel
A. Pisano.
               __________________________

                      ON MOTION
                __________________________

                       ORDER
   The appellants move to expedite briefing and argu-
ment.
    Upon consideration thereof,
Case: 13-1089    Document: 9   Page: 2    Filed: 12/07/2012

TAKEDA PHARMACEUTICALS CO. V. ZYDUS PHARMACEUTICALS     2
USA
     IT IS ORDERED THAT:
     (1) The motion to expedite briefing is granted to the
following extent: The appellants' opening brief is due
December 17. The appellees' brief is due January 2, 2013.
The appellants' reply brief and the joint appendix are due
January 9, 2013.
    (2) Oral argument will be scheduled by subsequent
order of the court.
                                  FOR THE COURT

                                  /s/ Jan Horbaly
                                  Jan Horbaly
                                  Clerk
s8